The latest price target for Biote (NASDAQ:BTMD) was reported by B. Riley Securities on March 12, 2026. The analyst firm set a price target for $2.00 expecting BTMD to rise to within 12 months (a possible 12.04% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Biote (NASDAQ:BTMD) was provided by B. Riley Securities, and Biote maintained their neutral rating.

There is no last upgrade for Biote

The last downgrade for Biote Corp happened on August 7, 2025 when B. Riley Securities changed their price target from $8 to $4 for Biote Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biote, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biote was filed on March 12, 2026 so you should expect the next rating to be made available sometime around March 12, 2027.

While ratings are subjective and will change, the latest Biote (BTMD) rating was a maintained with a price target of $3.00 to $2.00. The current price Biote (BTMD) is trading at is $1.79, which is out of the analyst’s predicted range.